Humana Inc. (HUM)
NYSE: HUM · Real-Time Price · USD
235.39
+0.13 (0.06%)
At close: Jun 16, 2025, 4:00 PM
236.00
+0.61 (0.26%)
Pre-market: Jun 17, 2025, 7:00 AM EDT
Humana Revenue
Humana had revenue of $32.11B in the quarter ending March 31, 2025, with 8.45% growth. This brings the company's revenue in the last twelve months to $120.26B, up 10.09% year-over-year. In the year 2024, Humana had annual revenue of $117.76B with 10.70% growth.
Revenue (ttm)
$120.26B
Revenue Growth
+10.09%
P/S Ratio
0.24
Revenue / Employee
$1,831,029
Employees
65,680
Market Cap
28.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 117.76B | 11.39B | 10.70% |
| Dec 31, 2023 | 106.37B | 13.50B | 14.54% |
| Dec 31, 2022 | 92.87B | 9.81B | 11.81% |
| Dec 31, 2021 | 83.06B | 5.91B | 7.66% |
| Dec 31, 2020 | 77.16B | 12.27B | 18.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
HUM News
- 4 days ago - Humana Recognizes 10 Inspiring Athletes Who Are Redefining What It Means to Age - Business Wire
- 4 days ago - athenahealth, Humana, and Your Health Closing Critical Gaps at the Point of Care While Reducing Administrative Burden on Clinicians - Business Wire
- 12 days ago - Humana to back curbs to Medicare Advantage billing practices, WSJ reports - Reuters
- 12 days ago - Humana, the second-biggest Medicare insurer, has told congressional staffers that it will support moves that would curtail billing practices worth billions in extra payments to the industry - WSJ
- 13 days ago - The Trade War Isn't Dead, But Neither Is This Blue-Chip Opportunity - Seeking Alpha
- 25 days ago - Humana Foundation Donates $50,000 to Support Long-Term Recovery in Tornado-Impacted Kentucky Communities - Business Wire
- 25 days ago - Top Stock Movers Now: Enphase Energy, Humana, Coinbase, and More - Investopedia
- 25 days ago - Humana and Other Health Insurer Stocks Fall as US Vows to Step Up Medicare Advantage Audits - Investopedia